Solid Biosciences Inc. — Director's Dealing 2018

Dec 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-12-13

Reporting Person: Freed Martin I (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-13	Director Stock Option (Right to Buy)	$23.58	A	16331	Acquired	2028-12-13	Common Stock (16331)	Direct

Footnotes

F1: This option was granted on December 13, 2018 and vests as to one-third of the total number of shares on each of July 25, 2019, July 25, 2020, and July 25, 2021, and will vest automatically as to 100% of the unvested portion of such option upon specified chage in control events.